For over a century, the medical community has striven to develop an oral insulin option, a significant improvement over daily injections. However, the challenge has always been the human digestive system, which efficiently breaks down insulin before it can be absorbed effectively, leaving millions of diabetic patients reliant on frequent needles.
Now, a promising development emerges from Kumamoto University. Researchers there have engineered an innovative solution: a minute peptide that acts as a kind of molecular ‘key,’ enabling insulin to successfully navigate and pass through the intestinal wall without degradation, bringing the long-sought insulin pill closer to reality.